Correlation Between Warner Music and COSCIENS Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Warner Music and COSCIENS Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Warner Music and COSCIENS Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Warner Music Group and COSCIENS Biopharma, you can compare the effects of market volatilities on Warner Music and COSCIENS Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Warner Music with a short position of COSCIENS Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Warner Music and COSCIENS Biopharma.

Diversification Opportunities for Warner Music and COSCIENS Biopharma

-0.15
  Correlation Coefficient

Good diversification

The 3 months correlation between Warner and COSCIENS is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Warner Music Group and COSCIENS Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COSCIENS Biopharma and Warner Music is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Warner Music Group are associated (or correlated) with COSCIENS Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COSCIENS Biopharma has no effect on the direction of Warner Music i.e., Warner Music and COSCIENS Biopharma go up and down completely randomly.

Pair Corralation between Warner Music and COSCIENS Biopharma

Considering the 90-day investment horizon Warner Music Group is expected to under-perform the COSCIENS Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Warner Music Group is 6.43 times less risky than COSCIENS Biopharma. The stock trades about -0.13 of its potential returns per unit of risk. The COSCIENS Biopharma is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  266.00  in COSCIENS Biopharma on October 10, 2024 and sell it today you would earn a total of  77.00  from holding COSCIENS Biopharma or generate 28.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.24%
ValuesDaily Returns

Warner Music Group  vs.  COSCIENS Biopharma

 Performance 
       Timeline  
Warner Music Group 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Warner Music Group are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable primary indicators, Warner Music is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
COSCIENS Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days COSCIENS Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental indicators, COSCIENS Biopharma is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders.

Warner Music and COSCIENS Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Warner Music and COSCIENS Biopharma

The main advantage of trading using opposite Warner Music and COSCIENS Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Warner Music position performs unexpectedly, COSCIENS Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in COSCIENS Biopharma will offset losses from the drop in COSCIENS Biopharma's long position.
The idea behind Warner Music Group and COSCIENS Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal